Showing results (131-140 of 212) with videos related to

Sort By:
Pageof 22
European Radiology|February 15, 2024
Artificial intelligence in immunotherapy PET/SPECT imagingJeremy P McGale, Delphine L Chen, Stefano Trebeschi, et al.
The Journal of Surgical Research|July 6, 2013
An engineered anti-CA19-9 cys-diabody for positron emission tomography imaging of pancreatic cancer and targeting of polymerized liposomal nanoparticlesMark D Girgis, Noah Federman, Matthew M Rochefort, et al.
Journal of Biomedical Optics|June 12, 2013
Activatable fluorescent cys-diabody conjugated with indocyanine green derivative: consideration of fluorescent catabolite kinetics on molecular imagingKohei Sano, Takahito Nakajima, Towhid Ali, et al.
Molecular Cancer Therapeutics|September 23, 2018
Targeted Delivery of Cytotoxic NAMPT Inhibitors Using Antibody-Drug ConjugatesChristopher S Neumann, Kathleen C Olivas, Martha E Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanomaKam Fai Tse, Michael Jeffers, Vincent A Pollack, et al.
Blood|June 18, 2013
SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AMLMay S Kung Sutherland, Roland B Walter, Scott C Jeffrey, et al.
Molecular Cancer Therapeutics|December 4, 2020
Development of Novel Antibody-Camptothecin ConjugatesRyan D Lyski, Lauren B Bou, Uland Y Lau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 19, 2014
Applications of immunoPET: using 124I-anti-PSCA A11 minibody for imaging disease progression and response to therapy in mouse xenograft models of prostate cancerScott M Knowles, Richard Tavaré, Kirstin A Zettlitz, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Minibody-indocyanine green based activatable optical imaging probes: the role of short polyethylene glycol linkersRira Watanabe, Kazuhide Sato, Hirofumi Hanaoka, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Integrating Artificial Intelligence and PET Imaging for Drug Discovery: A Paradigm Shift in ImmunotherapyJeremy P McGale, Harrison J Howell, Arnaud Beddok, et al.
Pageof 22